HANDOVER MEETING 23/10/2010 TNF a inhibitors BY: MOHAMMED ALSAIDAN Biologics Biologic agents are proteins that can be extracted from animal tissue or produced by recombinant…

Vol 59: APRIl • AVRIl 2013 | Canadian Family Physician • Le Médecin de famille canadien 379 Dermacase Answer to Dermacase continued from page 377 4. Pyoderma

Pyoderma Gangrenosum in a 17 month boy responsive to Corticosteroids and Infliximab: A Case ReportTitle Treatment of refractory pyoderma gangrenosum with infliximab in a

Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological TreatmentsREVIEW ARTICLE Pyoderma Gangrenosum: An Updated Literature Review

Novel use of apremilast for adjunctive treatment of recalcitrant pyoderma gangrenosumNovel use of apremilast for adjunctive treatment of recalcitrant pyoderma gangrenosum

Pyoderma GangrenosumPYODERMA GANGRENOSUM What are the aims of this leaflet? This leaflet has been written to help you understand more about pyoderma gangrenosum. It tells

G. Kontochristopoulos1*, E. Saxioni1, G. Doulaveri-Gherasim1, G. Politis2 and N. Zakopoulou1 1Second Department of Dermatology, ‘‘A. Syngros’’ Hospital,

Genital pyoderma gangrenosum revealing Behçet’s disease: a case reportChicha et al. The Egyptian Journal of Internal Medicine (2021) 33:52 https://doi.org/10.1186/s43162-021-00084-7

Nakamura_TODJ68 The Open Dermatology Journal, 2014, 8, 68-71 1874-3722/14 2014 Bentham Open Open Access Pyoderma Gangrenosum Following the Revision of a Breast Reconstruction

Idiopathic Pyoderma Gangrenosum in a Toddler: Case ReportWaleed Alajroush1*, Nouf Alqahtani2, Abdullah Alfaleh3 1Department of Pediatric Dermatology, King Abdullah Specialized